C. Patterson, E. Gyürüs, J. Rosenbauer, O. Cinek, A. Neu et al., Trends in childhood type 1 diabetes incidence in Europe during 1989???2008: evidence of non-uniformity over time in rates of increase, Diabetologia, vol.6, issue.8, 2012.
DOI : 10.1007/s00125-012-2571-8

I. L. Romon, incidence des admissions en affection de longue durée pour diabète chez l'enfant en France, InVS. BEH, pp.44-45, 2003.

C. Patterson, G. Dahlquist, E. Gyürüs, A. Green, and G. Soltész, Incidence trends for childhood type 1 diabetes in Europe during 1989???2003 and predicted new cases 2005???20: a multicentre prospective registration study, The Lancet, vol.373, issue.9680, 2009.
DOI : 10.1016/S0140-6736(09)60568-7

J. Bluestone, K. Herold, and G. Eisenbarth, Genetics, pathogenesis and clinical interventions in type???1 diabetes, Nature, vol.464, issue.7293, pp.1293-300, 2010.
DOI : 10.1038/nature08933

A. Willcox, S. Richardson, A. Bone, A. Foulis, and N. Morgan, Analysis of islet i nflammation in human type 1 diabetes, Clin Exp Immunol, 2009.

M. Gillespie, Non-HLA genes (revision number 36)
DOI : 10.14496/dia.2104311115.36

. Diapedia and . Org, Available from: http://www.diapedia.org, p.36, 2013.

K. Simmons and A. Michels, Type 1 diabetes: A predictable disease, World Journal of Diabetes, vol.6, issue.3, pp.380-90, 2015.
DOI : 10.4239/wjd.v6.i3.380

H. Mortensen, P. Hougaard, P. Swift, L. Hansen, R. Holl et al., New Definition for the Partial Remission Period in Children and Adolescents With Type 1 Diabetes. Diabetes Care, pp.1384-90, 2009.

M. Abdul-rasoul, H. Habib, and M. Khouly, 'The honeymoon phase' in children with type 1 diabetes mellitus: frequency, duration, and influential factors, Pediatric Diabetes, vol.21, issue.2, pp.101-108, 2006.
DOI : 10.1210/jc.85.12.4619

H. Chase, T. Mackenzie, J. Burdick, R. Fiallo-scharer, P. Walravens et al., Redefining the clinical remission period in children with type 1 diabetes. Pediatr Diabetes, pp.16-25, 2004.

A. Schölin, C. Berne, E. Schvarcz, F. Karlsson, and E. Björk, Factors predicting clinical remission in adult patients with type 1 diabetes, Journal of Internal Medicine, vol.15, issue.2, pp.155-62, 1999.
DOI : 10.1210/jc.75.6.1574

S. Bowden, M. Duck, and R. Hoffman, Young children (<5??yr) and adolescents (>12??yr) with type 1 diabetes mellitus have low rate of partial remission: diabetic ketoacidosis is an important risk factor, Pediatric Diabetes, vol.315, issue.3pt1, pp.197-201, 2008.
DOI : 10.1055/s-2007-948214

E. Böber, B. Dündar, and A. Büyükgebiz, Partial Remission Phase and Metabolic Control in Type 1 Diabetes Mellitus in Children and Adolescents, Journal of Pediatric Endocrinology and Metabolism, vol.14, issue.4, pp.435-476, 2001.
DOI : 10.1515/JPEM.2001.14.4.435

A. Dost, A. Herbst, K. Kintzel, H. Haberland, C. Roth et al., Shorter Remission Period in Young Versus Older Children with Diabetes Mellitus Type 1, Experimental and Clinical Endocrinology & Diabetes, vol.115, issue.1
DOI : 10.1055/s-2007-948214

P. Pozzilli, C. Mesturino, A. Crino, T. Gross, L. Jeng et al., Is the process of beta-cell destruction in type 1 diabetes at time of diagnosis more extensive in females than in males?, European Journal of Endocrinology, vol.145, issue.6, pp.757-61, 2001.
DOI : 10.1530/eje.0.1450757

T. Hawkins, R. Gala, and J. Dunbar, The Effect of Neonatal Sex Hormone Manipulation on the Incidence of Diabetes in Nonobese Diabetic Mice, Experimental Biology and Medicine, vol.202, issue.2, pp.201-206, 1993.
DOI : 10.3181/00379727-202-43527

A. Szadkowska, I. Pietrzak, B. Mianowska, J. Bodalska-lipi?ska, H. Keenan et al., Insulin sensitivity in Type??1 diabetic children and adolescents, Diabetic Medicine, vol.59, issue.3, pp.282-290, 2008.
DOI : 10.2337/diacare.26.1.138

F. Lombardo, M. Valenzise, M. Wasniewska, M. Messina, C. Ruggeri et al., Two-year prospective evaluation of the factors affecting honeymoon frequency and duration in children with insulin dependent diabetes mellitus: the key-role of age at diagnosis. Diabetes Nutr Metab, pp.246-51, 2002.

R. Bonfanti, E. Bazzigaluppi, G. Calori, M. Riva, M. Viscardi et al., Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus, Diabetic Medicine, vol.15, issue.10, pp.844-50, 1998.
DOI : 10.1002/(SICI)1096-9136(199810)15:10<844::AID-DIA679>3.0.CO;2-A

J. Komulainen, R. Lounamaa, M. Knip, E. Kaprio, and H. Akerblom, Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function. Childhood Diabetes in Finland Study Group., Archives of Disease in Childhood, vol.75, issue.5, pp.410-415, 1996.
DOI : 10.1136/adc.75.5.410

J. Meier, A. Butler, Y. Saisho, T. Monchamp, R. Galasso et al., ??-Cell Replication Is the Primary Mechanism Subserving the Postnatal Expansion of ??-Cell Mass in Humans, Diabetes, vol.57, issue.6, pp.1584-94, 2008.
DOI : 10.2337/db07-1369

J. Couper, I. Hudson, G. Werther, G. Warne, J. Court et al., Factors predicting residual ??-cell function in the first year after diagnosis of childhood type 1 diabetes, Diabetes Research and Clinical Practice, vol.11, issue.1, pp.9-16, 1991.
DOI : 10.1016/0168-8227(91)90135-Z

M. Fernandez-castañer, E. Montaña, I. Camps, J. Biarnes, J. Merino et al., Ketoacidosis at diagnosis is predictive of lower residual beta-cell function and poor metabolic control in type 1 diabetes, Diabetes Metab, 1996.

E. Akirav, J. Kushner, and K. Herold, ??-Cell Mass and Type 1 Diabetes: Going, Going, Gone?, Diabetes, vol.57, issue.11, pp.2883-2891, 2008.
DOI : 10.2337/db07-1817

V. Herrath, M. Sanda, S. Herold, and K. , Type 1 diabetes as a relapsing?remitting disease? Nat Rev Immunol, pp.988-94, 2007.

S. Martin, B. Pawlowski, B. Greulich, A. Ziegler, T. Mandrup-poulsen et al., Natural course of remission in IDDM during 1st yr after diagnosis. Diabetes Care, pp.66-74, 1992.

R. Veijola, M. Knip, H. Reijonen, P. Vahasalo, R. Puukka et al., Effect of genetic risk load defined by HLA-DQB1 polymorphism on clinical characteristics of ID DM in children, European Journal of Clinical Investigation, vol.5, issue.2, pp.106-118, 1995.
DOI : 10.1203/00006450-199305000-00016

. Glutamic-acid-decarboxylase, Autoantibodies in Prediction of ?-Cell Function and Remission in Recent-Onset IDDM After Cyclosporin Treatment. Diabetes, pp.1291-1297, 1994.

J. Krischer, D. Cuthbertson, L. Yu, T. Orban, N. Maclaren et al., Screening Strategies for the Identification of Multiple Antibody-Positive Relatives of Individuals with Type 1 Diabetes, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.1, 2003.
DOI : 10.1210/jc.2002-020760

J. Sørensen, J. Johannesen, F. Pociot, K. Kristensen, J. Thomsen et al., Residual ?-Cell Function 3?6 Years After Onset of Type 1 Diabetes Reduces Risk of Severe Hypoglycemia in Children and Adolescents. Diabetes Care, pp.3454-3463, 2013.

K. Näntö-salonen, A. Kupila, S. Simell, H. Siljander, T. Salonsaari et al., Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial, The Lancet, vol.372, issue.9651, pp.1746-55, 2008.
DOI : 10.1016/S0140-6736(08)61309-4

E. Gale, European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes, The Lancet, vol.363, issue.9413
DOI : 10.1016/S0140-6736(04)15786-3

G. Hale, Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1

M. Pescovitz, C. Greenbaum, H. Krause-steinrauf, D. Becker, S. Gitelman et al., Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function, New England Journal of Medicine, vol.361, issue.22, pp.2143-52, 2009.
DOI : 10.1056/NEJMoa0904452